Medibank Private Limited (ASX:MPL)
Australia · Delayed Price · Currency is AUD 4.810
-0.030 (-0.62%)
Sep 1, 2026, 4:10 PM AEST
Medibank Private Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Investments in Equity & Preferred Securities | 32.5 | 39 | 58.7 | 117.6 | 103.7 |
Other Investments | 97.8 | 245 | 221.6 | 209.7 | 176.2 |
Total Investments | 2,965 | 3,102 | 3,107 | 2,984 | 2,958 |
Cash & Equivalents | 570.4 | 648.6 | 691 | 420.6 | 596.7 |
Other Receivables | 105.7 | 66.4 | 39.5 | 139 | 225.4 |
Deferred Policy Acquisition Cost | - | - | - | - | 82.9 |
Property, Plant & Equipment | 259.3 | 194.2 | 205 | 70.5 | 88.4 |
Goodwill | 507.3 | 342.4 | 323.7 | 204.5 | 204.5 |
Other Intangible Assets | 182 | 157.5 | 143.3 | 123.6 | 127.8 |
Other Current Assets | 38.5 | 34.1 | 27.6 | 25.9 | 19.3 |
Long-Term Deferred Tax Assets | 114.6 | 146.5 | 142.1 | 62.4 | 243.6 |
Other Long-Term Assets | 10.6 | 9.1 | 6.3 | 3.5 | 6 |
Total Assets | 4,753 | 4,700 | 4,685 | 4,034 | 4,553 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 190.2 | 170.5 | 145.4 | 99.8 | 241.4 |
Accrued Expenses | 133.2 | 100.2 | 85.1 | 65.3 | 72.4 |
Insurance & Annuity Liabilities | 1,587 | 1,754 | 1,802 | 1,506 | - |
Unpaid Claims | - | - | - | - | 871.1 |
Unearned Premiums | - | - | - | - | 894.8 |
Current Portion of Leases | 39.1 | 29.2 | 31.7 | 30.9 | 30.2 |
Short-Term Debt | - | 35 | 34.9 | - | - |
Current Income Taxes Payable | 39.1 | 34.4 | 48.7 | - | 117 |
Long-Term Debt | 35.9 | - | - | - | - |
Long-Term Leases | 198.9 | 144.8 | 151.7 | 24.4 | 46.7 |
Other Current Liabilities | 7.5 | 28.4 | 32.9 | 28.7 | 300.6 |
Other Long-Term Liabilities | 111.6 | 67.8 | 48 | 35.6 | 33 |
Total Liabilities | 2,342 | 2,364 | 2,380 | 1,791 | 2,607 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 85 | 85 | 85 | 85 | 85 |
Retained Earnings | 2,353 | 2,224 | 2,068 | 1,925 | 1,835 |
Comprehensive Income & Other | -7 | 27.4 | 152.3 | 233.5 | 25.7 |
Total Common Equity | 2,431 | 2,336 | 2,306 | 2,244 | 1,946 |
Minority Interest | -20 | 0.2 | -0.6 | - | - |
Shareholders' Equity | 2,411 | 2,336 | 2,305 | 2,244 | 1,946 |
Total Liabilities & Equity | 4,753 | 4,700 | 4,685 | 4,034 | 4,553 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Filing Date Shares Outstanding | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 |
Total Common Shares Outstanding | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 |
Total Debt | 273.9 | 209 | 218.3 | 55.3 | 76.9 |
Net Cash (Debt) | 296.5 | 439.6 | 472.7 | 365.3 | 519.8 |
Net Cash Growth | -32.55% | -7.00% | 29.40% | -29.72% | -10.12% |
Net Cash Per Share | 0.11 | 0.16 | 0.17 | 0.13 | 0.19 |
Book Value Per Share | 0.88 | 0.85 | 0.84 | 0.81 | 0.71 |
Tangible Book Value | 1,741 | 1,836 | 1,839 | 1,916 | 1,613 |
Tangible Book Value Per Share | 0.63 | 0.67 | 0.67 | 0.70 | 0.59 |
Machinery | 27.7 | 19.6 | 30.6 | 26.9 | 23.6 |
Construction In Progress | 3.9 | 4.7 | 3.3 | 5.7 | 7.1 |
Leasehold Improvements | 144.1 | 119.2 | 172.4 | 99.5 | 96 |